Ocaña, A., Amir, E., & Pandiella, A. (2018). Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: Understanding clinical trial results.
Chicago Style CitationOcaña, Alberto, Eitan Amir, and Atanasio Pandiella. Dual Targeting of HER2-positive Breast Cancer With Trastuzumab Emtansine and Pertuzumab: Understanding Clinical Trial Results. 2018.
MLA CitationOcaña, Alberto, Eitan Amir, and Atanasio Pandiella. Dual Targeting of HER2-positive Breast Cancer With Trastuzumab Emtansine and Pertuzumab: Understanding Clinical Trial Results. 2018.
Warning: These citations may not always be 100% accurate.